CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 84% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Scan to Download iOS&Android APP

Trade icad - ICADus CFD

2.0373
2.4%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.0654
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.024068%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
0.001846%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 20%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 2.0873
Open* 2.0873
1-Year Change* -64.92%
Day's Range* 2.0073 - 2.1172
52 wk Range 1.25-4.68
Average Volume (10 days) 231.80K
Average Volume (3 months) 3.01M
Market Cap 32.32M
P/E Ratio -100.00K
Shares Outstanding 25.45M
Revenue 29.26M
EPS -0.58
Dividend (Yield %) N/A
Beta 1.26
Next Earnings Date Mar 28, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 10, 2023 2.0373 -0.0499 -2.39% 2.0872 2.1172 2.0073
Feb 9, 2023 2.0873 -0.1198 -5.43% 2.2071 2.2271 1.9973
Feb 8, 2023 2.1871 -0.1099 -4.78% 2.2970 2.3769 2.1372
Feb 7, 2023 2.2770 0.0100 0.44% 2.2670 2.3170 2.1372
Feb 6, 2023 2.2770 -0.0799 -3.39% 2.3569 2.3969 2.1372
Feb 3, 2023 2.3669 0.0500 2.16% 2.3169 2.3869 2.2970
Feb 2, 2023 2.3969 0.1299 5.73% 2.2670 2.4268 2.2570
Feb 1, 2023 2.2770 -0.0200 -0.87% 2.2970 2.3370 2.1971
Jan 31, 2023 2.2870 0.0400 1.78% 2.2470 2.3270 2.2171
Jan 30, 2023 2.1871 -0.0599 -2.67% 2.2470 2.2471 2.1372
Jan 27, 2023 2.2371 0.0999 4.67% 2.1372 2.2970 2.1372
Jan 26, 2023 2.1472 0.0000 0.00% 2.1472 2.1572 2.0772
Jan 25, 2023 2.1572 -0.0399 -1.82% 2.1971 2.1971 2.0872
Jan 24, 2023 2.2271 -0.0299 -1.32% 2.2570 2.2770 2.2071
Jan 23, 2023 2.2570 -0.0200 -0.88% 2.2770 2.2970 2.1971
Jan 20, 2023 2.2970 0.0800 3.61% 2.2170 2.3070 2.1671
Jan 19, 2023 2.2371 -0.0099 -0.44% 2.2470 2.2770 2.1771
Jan 18, 2023 2.2171 0.0300 1.37% 2.1871 2.2371 2.1472
Jan 17, 2023 2.1871 -0.0200 -0.91% 2.2071 2.2071 2.1571
Jan 13, 2023 2.1672 0.0999 4.83% 2.0673 2.2670 2.0073

icad Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total revenue 33.638 29.698 31.34 25.621 28.102
Revenue 33.638 29.698 31.34 25.621 28.102
Cost of Revenue, Total 9.395 8.344 7.113 6.191 9.926
Gross Profit 24.243 21.354 24.227 19.43 18.176
Total Operating Expense 44.756 39.427 37.737 33.751 42.27
Selling/General/Admin. Expenses, Total 25.541 22.429 21.077 17.81 18.38
Research & Development 9.194 8.114 9.271 9.445 9.327
Depreciation / Amortization 0.24 0.199 0.276 0.305 0.452
Unusual Expense (Income) 0.386 0.341 0 4.185
Operating Income -11.118 -9.729 -6.397 -8.13 -14.168
Interest Income (Expense), Net Non-Operating -0.126 -7.843 -7.111 -0.845 -0.106
Net Income Before Taxes -11.244 -17.572 -13.508 -8.975 -14.274
Net Income After Taxes -11.245 -17.61 -13.551 -9.017 4.844
Net Income Before Extra. Items -11.245 -17.61 -13.551 -9.017 4.844
Net Income -11.245 -17.61 -13.551 -9.017 -14.256
Income Available to Common Excl. Extra. Items -11.245 -17.61 -13.551 -9.017 4.844
Income Available to Common Incl. Extra. Items -11.245 -17.61 -13.551 -9.017 -14.256
Diluted Net Income -11.245 -17.61 -13.551 -9.017 -14.256
Diluted Weighted Average Shares 24.778 22.14 18.378 16.685 16.343
Diluted EPS Excluding Extraordinary Items -0.45383 -0.79539 -0.73735 -0.54043 0.2964
Diluted Normalized EPS -0.4437 -0.78538 -0.73735 -0.54043 0.46284
Total Extraordinary Items -19.1
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total revenue 7.523 7.808 9.361 7.826 8.644
Revenue 7.523 7.808 9.361 7.826 8.644
Cost of Revenue, Total 2.211 2.104 2.649 2.288 2.355
Gross Profit 5.312 5.704 6.712 5.538 6.289
Total Operating Expense 11.045 11.956 11.542 11.083 10.177
Selling/General/Admin. Expenses, Total 6.496 7.341 6.544 6.081 5.575
Research & Development 2.275 2.449 2.285 2.268 2.192
Depreciation / Amortization 0.063 0.062 0.064 0.06 0.055
Unusual Expense (Income) 0 0 0.386 0
Operating Income -3.522 -4.148 -2.181 -3.257 -1.533
Interest Income (Expense), Net Non-Operating -0.009 0.003 0.005 -0.023 -0.11
Net Income Before Taxes -3.544 -4.145 -2.176 -3.28 -1.643
Net Income After Taxes -3.545 -4.146 -2.176 -3.28 -1.643
Net Income Before Extra. Items -3.545 -4.146 -2.176 -3.28 -1.643
Net Income -3.545 -4.146 -2.176 -3.28 -1.643
Income Available to Common Excl. Extra. Items -3.544 -4.146 -2.176 -3.28 -1.643
Income Available to Common Incl. Extra. Items -3.544 -4.146 -2.176 -3.28 -1.643
Diluted Net Income -3.544 -4.146 -2.176 -3.28 -1.643
Diluted Weighted Average Shares 25.16 25.126 25.053 24.989 23.929
Diluted EPS Excluding Extraordinary Items -0.14086 -0.16501 -0.08686 -0.13126 -0.06866
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.14086 -0.16501 -0.08686 -0.11581 -0.06866
Other, Net -0.013
Total Adjustments to Net Income 0.001
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total Current Assets 50.306 42.302 29.196 21.22 21.209
Cash and Short Term Investments 34.282 27.186 15.313 12.185 9.387
Cash & Equivalents 34.282 27.186 15.313 12.185 9.387
Total Receivables, Net 10.786 10.508 9.833 6.422 8.599
Accounts Receivable - Trade, Net 10.786 10.508 9.833 6.422 8.599
Total Inventory 4.171 3.144 2.611 1.587 2.123
Prepaid Expenses 1.067 1.464 1.439 1.026 1.1
Other Current Assets, Total 0
Total Assets 62.191 55.582 41.748 31.737 32.131
Property/Plant/Equipment, Total - Net 1.941 2.502 2.957 0.552 0.576
Property/Plant/Equipment, Total - Gross 9.047 9.28 9.467 6.766 6.465
Accumulated Depreciation, Total -7.106 -6.778 -6.51 -6.214 -5.889
Goodwill, Net 8.362 8.362 8.362 8.362 8.362
Intangibles, Net 0.683 0.889 1.183 1.55 1.931
Other Long Term Assets, Total 0.055 0.093 0.05 0.053 0.053
Total Current Liabilities 14.962 16.751 18.836 13.245 12.07
Accounts Payable 2.779 2.869 1.99 1.154 1.362
Accrued Expenses 6.531 7.765 7.336 4.968 4.399
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0 0 4.262 1.866 0.829
Other Current Liabilities, Total 5.652 6.117 5.248 5.257 5.48
Total Liabilities 15.674 25.057 36.677 24.841 17.855
Total Long Term Debt 0 6.96 15.645 11.235 5.146
Capital Lease Obligations 0.011 0.027
Deferred Income Tax 0.005 0.004 0.003 0.003 0.014
Other Liabilities, Total 0.707 1.342 2.193 0.358 0.625
Total Equity 46.517 30.525 5.071 6.896 14.276
Preferred Stock - Non Redeemable, Net 0 0
Common Stock 0.253 0.236 0.196 0.171 0.167
Additional Paid-In Capital 300.859 273.639 230.615 218.914 217.389
Retained Earnings (Accumulated Deficit) -253.18 -241.935 -224.325 -210.774 -201.865
Treasury Stock - Common -1.415 -1.415 -1.415 -1.415 -1.415
Total Liabilities & Shareholders’ Equity 62.191 55.582 41.748 31.737 32.131
Total Common Shares Outstanding 25.1403 23.5086 19.3603 16.8807 16.5259
Long Term Debt 0 6.96 15.645 11.224 5.119
Note Receivable - Long Term 0.844 1.434
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total Current Assets 47.933 50.306 52.876 53.599 62.242
Cash and Short Term Investments 29.798 34.282 35.805 37.889 46.907
Cash & Equivalents 29.798 34.282 35.805 37.889 46.907
Total Receivables, Net 11.483 10.786 12.45 11.849 11.35
Accounts Receivable - Trade, Net 11.483 10.786 12.45 11.849 11.35
Total Inventory 4.736 4.171 3.29 2.861 2.498
Prepaid Expenses 1.916 1.067 1.331 1 1.487
Total Assets 58.845 62.191 65.737 66.561 75.494
Property/Plant/Equipment, Total - Net 1.806 1.941 2.101 2.291 2.495
Property/Plant/Equipment, Total - Gross 8.139 7.988 7.945 7.856 7.784
Accumulated Depreciation, Total -7.192 -7.106 -7.02 -6.935 -6.854
Goodwill, Net 8.362 8.362 8.362 8.362 8.362
Intangibles, Net 0.64 0.683 0.741 0.777 0.831
Note Receivable - Long Term 0.049 0.844 1.602 1.478 1.478
Other Long Term Assets, Total 0.055 0.055 0.055 0.054 0.086
Total Current Liabilities 14.461 14.962 14.96 14.46 14.143
Accounts Payable 2.681 2.779 2.651 1.039 1.251
Accrued Expenses 6.015 6.531 6.379 7.457 6.666
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0 0 0.269
Other Current Liabilities, Total 5.765 5.652 5.93 5.964 5.957
Total Liabilities 15.092 15.674 15.916 15.534 22.13
Total Long Term Debt 0 0 0 0 6.703
Long Term Debt 0 0 0 6.703
Deferred Income Tax 0.006 0.005 0.005 0.004 0.004
Other Liabilities, Total 0.625 0.707 0.951 1.07 1.28
Total Equity 43.753 46.517 49.821 51.027 53.364
Common Stock 0.253 0.253 0.253 0.251 0.251
Additional Paid-In Capital 301.64 300.859 300.017 299.049 298.106
Retained Earnings (Accumulated Deficit) -256.725 -253.18 -249.034 -246.858 -243.578
Treasury Stock - Common -1.415 -1.415 -1.415 -1.415 -1.415
Total Liabilities & Shareholders’ Equity 58.845 62.191 65.737 66.561 75.494
Total Common Shares Outstanding 25.1733 25.1403 25.102 25.0275 24.9576
Preferred Stock - Non Redeemable, Net 0 0 0
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Net income/Starting Line -11.245 -17.61 -13.551 -9.017 -14.256
Cash From Operating Activities -9.408 -6.985 -7.107 -3.867 -7.337
Cash From Operating Activities 0.327 0.268 0.297 0.325 0.995
Amortization 0.23 0.309 0.377 0.383 0.494
Deferred Taxes 0.001 0.001 0.001 -0.012 0.008
Non-Cash Items 3.45 10.821 8.051 1.912 9.366
Cash Taxes Paid 0 0.038 0.043 0.051 0.06
Cash Interest Paid 0.172 0.272 0.643 0.294 0.079
Changes in Working Capital -2.171 -0.774 -2.282 2.542 -3.944
Cash From Investing Activities -0.587 -0.474 -0.306 -0.316 2.455
Capital Expenditures -0.587 -0.474 -0.306 -0.316 -0.395
Other Investing Cash Flow Items, Total 0 2.85
Cash From Financing Activities 17.091 19.332 10.541 6.981 5.684
Financing Cash Flow Items -0.059 -0.267 -0.196 -0.18 -0.315
Issuance (Retirement) of Stock, Net 24.513 19.28 10.753 0.204 0.079
Issuance (Retirement) of Debt, Net -7.363 0.319 -0.016 6.957 5.92
Net Change in Cash 7.096 11.873 3.128 2.798 0.802
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -3.545 -11.245 -7.099 -4.923 -1.643
Cash From Operating Activities -4.449 -9.408 -7.861 -5.577 -3.563
Cash From Operating Activities 0.086 0.327 0.242 0.115 0.076
Amortization 0.053 0.23 0.176 0.157 0.058
Deferred Taxes 0.001 0 0 0
Non-Cash Items 0.961 3.45 2.48 1.846 0.947
Cash Taxes Paid 0 0 0 0
Cash Interest Paid 0.009 0.172 0.092 0.092 0.092
Changes in Working Capital -2.004 -2.171 -3.66 -2.772 -3.001
Cash From Investing Activities -0.161 -0.587 -0.45 -0.336 -0.262
Capital Expenditures -0.161 -0.587 -0.45 -0.336 -0.262
Cash From Financing Activities 0.126 17.091 16.93 16.616 23.546
Financing Cash Flow Items -0.059 -0.059 0 0
Issuance (Retirement) of Stock, Net 0.126 24.513 24.352 23.979 23.546
Issuance (Retirement) of Debt, Net -7.363 -7.363 -7.363 0
Net Change in Cash -4.484 7.096 8.619 10.703 19.721
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Granahan Investment Management, Inc. Investment Advisor 11.1966 2849124 270454 2022-12-31 LOW
Pura Vida Investments, LLC Hedge Fund 5.0192 1277214 168545 2023-03-10 MED
Victory Capital Management Inc. Investment Advisor/Hedge Fund 4.99 1269785 67200 2022-12-31 LOW
Sassine (Andy H) Individual Investor 4.8666 1238382 43500 2022-04-29 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 4.1493 1055845 485 2022-12-31 LOW
First Eagle Investment Management, L.L.C. Investment Advisor/Hedge Fund 2.8628 728484 179498 2022-12-31 LOW
Essex Investment Management Company, LLC Investment Advisor/Hedge Fund 1.738 442261 -21947 2022-12-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 1.4337 364813 545 2022-12-31 LOW
Greenwood Capital Associates, LLC Investment Advisor 1.2951 329568 102369 2022-12-31 MED
Portolan Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.2897 328175 -83549 2022-12-31 HIGH
Perritt Capital Management, Inc. Investment Advisor 1.0794 274666 102016 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.8731 222163 3261 2022-12-31 LOW
JP Morgan Asset Management Investment Advisor 0.8641 219878 0 2022-12-31 LOW
ACT Capital Management, L.L.C. Hedge Fund 0.8056 205000 0 2022-09-30 MED
Go (Jonathan) Individual Investor 0.7417 188725 6040 2022-09-12 LOW
Two Sigma Investments, LP Hedge Fund 0.7265 184862 -68362 2022-12-31 HIGH
Dalton (Nathaniel) Individual Investor 0.7229 183947 6900 2022-04-29 LOW
GWM Advisors LLC Investment Advisor 0.683 173801 -463 2022-12-31 MED
DWS Investments UK Limited Investment Advisor 0.683 173787 0 2022-12-31 MED
Renaissance Technologies LLC Hedge Fund 0.59 150133 -61557 2022-12-31 HIGH

Why choose Capital.com? Our numbers speak for themselves.

Capital.com Group

500K+

Traders

92K+

Active clients monthly

$53M+

Monthly investing volume

$30M+

Withdrawn each month

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

icad Company profile

About iCAD Inc

iCAD, Inc. is a global medical technology company providing cancer detection and therapy solutions. The Company operates through two segments: Cancer Detection (Detection) and Cancer Therapy (Therapy). The Detection segment consists of its image analysis and workflow products, a range of Artificial Intelligence (AI), Computer-Aided Detection (CAD) systems and workflow solutions for two-dimensional (2D) and three-dimensional (3D) mammography, Magnetic Resonance Imaging (MRI) and Computed Tomography (CT). The Therapy segment consists of its radiation therapy products and offers the Xoft System, which is an isotope-free cancer treatment platform technology. The Company sells its products through its direct sales organization, as well as through various original equipment manufacturer partners, distributors and resellers.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, iCAD Inc revenues increased 13% to $33.6M. Net loss decreased 36% to $11.2M. Revenues reflect Products increase of 12% to $21.2M, Service and supplies increase of 15% to $12.4M. Lower net loss reflects Loss on fair value of convertible debent decrease from $7.5M (expense) to $0K. Basic Earnings per Share excluding Extraordinary Items increased from -$0.80 to -$0.45.

Equity composition

Common Stock $.01 Par, 12/10, 85M auth., 54,383,747 issd., less 67,876 shs. in Treas. @ $950K. Insiders & Strategic holders own 20.72%. PO 12/84, 1.25M shares @ $5 by Whale Secs. Convertible Preferred Stock $.01 Par, 1M auth., 0 issd. *7/02, Co. merged with Intelligent Systems Software, Inc. 08/12, 1-For-5 Reverse stock split.

Industry: Advanced Medical Equipment & Technology (NEC)

98 Spit Brook Rd Ste 100
03062-5737

Income Statement

  • Annual
  • Quarterly

People also watch

Oil - Crude

69.51 Price
+2.430% 1D Chg, %
Long position overnight fee -0.0194%
Short position overnight fee -0.0026%
Overnight fee time 21:00 (UTC)
Spread 0.04

BTC/USD

28,194.80 Price
+0.310% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 66.00

US100

12,736.10 Price
+1.350% 1D Chg, %
Long position overnight fee -0.0241%
Short position overnight fee 0.0018%
Overnight fee time 21:00 (UTC)
Spread 1.8

Gold

1,943.46 Price
-1.800% 1D Chg, %
Long position overnight fee -0.0177%
Short position overnight fee 0.0095%
Overnight fee time 21:00 (UTC)
Spread 0.33

Still looking for a broker you can trust?

Join the 500.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading